Shine Investment Advisory Services’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$14K Hold
125
﹤0.01% 498
2020
Q2
$14K Sell
125
-248
-66% -$26.3K 0.01% 502
2020
Q1
$30K Hold
373
0.01% 352
2019
Q4
$40K Hold
373
0.02% 362
2019
Q3
$40K Hold
373
0.02% 347
2019
Q2
$38K Hold
373
0.02% 356
2019
Q1
$34K Hold
373
0.02% 373
2018
Q4
$31K Hold
373
0.02% 354
2018
Q3
$40K Hold
373
0.02% 336
2018
Q2
$41K Hold
373
0.02% 344
2018
Q1
$37K Buy
373
+248
+198% +$25.4K 0.02% 359
2017
Q4
$12K Hold
125
0.01% 509
2017
Q3
$12K Hold
125
0.01% 507
2017
Q2
$14K Buy
+125
New +$13.2K 0.01% 480

Other funds holding DGX

Shine Investment Advisory Services's DGX Position: Q3 2020 in Review

Shine Investment Advisory Services held its Quest Diagnostics (DGX) position steady in Q3 2020 at 125 shares worth $14K. The position accounts for ﹤0.01% of the portfolio, ranked #498.

Shine Investment Advisory Services first reported a position in DGX in Q2 2017 and has held it in 14 quarters since. The position peaked at $41K in Q2 2018. 758 funds tracked by Wall St. Rank hold DGX as of Q3 2020.

  • Shine Investment Advisory Services held 125 shares of Quest Diagnostics worth $14K as of Q3 2020.
  • Shine Investment Advisory Services left its Quest Diagnostics share count unchanged in Q3 2020.
  • Quest Diagnostics made up ﹤0.01% of Shine Investment Advisory Services's portfolio in Q3 2020, its #498 holding.
  • Shine Investment Advisory Services first reported a position in Quest Diagnostics in Q2 2017 and has held it in 14 quarters since.
  • Shine Investment Advisory Services's Quest Diagnostics position peaked at $41K in Q2 2018.
  • 758 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2020.

Based on Shine Investment Advisory Services's 13F filing for Q3 2020, filed 3 Nov 2020.